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ABSTRACT
Patient’s adherence is crucial to get the best out of antiretroviral therapy (ART). This study explores in-depth 
the barriers to and facilitators of ART adherence among Nepalese patients and service providers prescribing 
ART. Face-to-face semi-structured interviews were conducted with 34 participants. Interviews were audio-
taped, transcribed, and translated into English before being analyzed thematically. ART-prescribed patients 
described a range of barriers for failing to adhere to ART. Financial difficulties, access to healthcare 
services, frequent transport blockades, religious/ritual obstacles, stigma and discrimination, and side-
effects were the most-frequently discussed barriers whereas trustworthy health workers, perceived health 
benefits, and family support were the most-reported facilitators. Understanding barriers and facilitators can 
help in the design of an appropriate and targeted intervention. Healthcare providers should address some 
of the practical and cultural issues around ART whilst policy-makers should develop appropriate social 
policy to promote adherence among ART-prescribed patients.
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INTRODUCTION
Antiretroviral therapy (ART) has dramatic posi-
tive effects on the lifespan and quality of life of 
people living with HIV (PLWH). ART reduces the 
load of human immunodeficiency virus (HIV) 
and increases CD4 cell counts, delaying progres-
sion to acquired immune deficiency syndrome 
(AIDS) and reducing morbidity and mortality 
(1). Since 2004, Nepal has been providing free-of-
charge ART nationwide but the cost of diagnostic 
tests and travel costs must be paid for by patients 
(2). By the end of 2009, over 2,586 adults out of 
an estimated 63,528 PLWH received free ART at 
23 sites across the country (4.1%) (3). 
The distribution of HIV prevalence across the 
country is uneven. Almost 50% of all PLWH 
live  in the highway districts, followed by 19% 
in the hill districts and 16% in the Far-western 
and Kathmandu valley (3). Despite numerous 
efforts by the Government of Nepal, the uptake 
of ART is poor due to a range of barriers and 
obstacles, including geographical barriers, lim-
ited infrastructure (i.e. lack of facilities for CD4 
assessment, clinicians, and adequate space), fi-
nancial constraints, and weak leadership and 
management at the national level (4). These 
barriers may also affect the adherence to ART by 
PLWH in Nepal.  
Simply making ART available to PLWH is not 
enough as strict adherence is required for treat-
ment success (5). Adherence is vital to the effec-
tiveness of the ART as it is associated with clin-
ically-significant reduction in viral load, lower 
drug resistance, and slower progression to AIDS 
(6,7). Unfortunately, up to 25% of patients do 
not adhere to ART (8). Both developed and de-
veloping countries have found a range of barri-
ers to both starting and maintaining treatment, 
which relate to patients, healthcare systems, 
costs, stigma and discrimination, and treatment 
regimens (9-12). Facilitators of ART include fi-
nancial assistance, good relationship with care 
providers, family support, and disclosure of HIV 
status to others (10,12).  
It is important to study adherence in the cultur-
al context of applying the theory of attribution 
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(13) because Nepal is a multicultural and multi-
ethnic society (14) where beliefs about health 
and illness vary between population groups. 
People’s  beliefs and social knowledge help them 
interpret events, derive meaning from them, and 
ascribe value to them within their social group 
(15). Culture is the collective consciousness that 
defines individual behaviours and leads to the 
interpretation of the world around us (16). It is de-
scribed as social glue and is a socially-constructed 
phenomenon which can be shaped by groups 
that people belong to (17). Understanding cul-
ture as an internal (i.e. values, rules) or external 
(national culture) variable can help improve ad-
herence. These two variables are keys to under-
standing the patterns of assumptions, beliefs, 
practices, and artifacts (18,19). The theory of 
attribution can help us understand these cul-
tural issues and how they affect adherence to 
ART, how people explain their experiences and 
how attributions may influence their behaviour 
(20). It seems plausible that individuals who 
share similar basic assumptions interpret events 
in similar ways. For example, if patients adhere, 
they attribute this to internal strength whereas 
if they fail, rather than blaming themselves they 
attribute this to situational factors, such as be-
ing busy, financial difficulties, pills run-out, and 
side-effects (20,21). Thus, adherence is attributed 
to internal stable factors while non-adherence is 
attributed to external and, hence, uncontrolla-
ble factors (20). As a result, this study will focus 
on both the internal and external factors that 
promote or prevent adherence to ART. We are 
not aware of a similar study of this type con-
ducted in Nepal. 
MATERIALS AND METHODS
Qualitative research is widely used in health and 
social sciences around sensitive issues (22), and 
HIV in Nepal is stigmatized and sensitive (4). 
We examined the views of PLWH in their natu-
ral settings to identify contextual influences of 
adherence to ART (23,24). Purposive sampling 
technique was used in selecting 34 interviewees 
for face-to-face semi-structured interviews. This 
method is often used when the researcher has 
specific requirements for the sample and picks a 
subject who meets these strict criteria (24). The 
sample comprised 17 ART-prescribed patients, 
14 ART service providers (doctors, nurses, and 
paramedics), and three policy-makers. ART- 
prescribed patients were recruited through ac-
cessing medical records for patients who missed 
refill prescription as well as those who never 
missed. Similarly, ART service providers and key 
policy-makers were identified, who were closely 
working with the ART programme. Data were 
considered saturated when no more new infor-
mation could be obtained (25). 
Interviews were conducted with the aid of an in-
terview checklist and included probes for further 
questioning (24), covering questions on how 
ART fitted into their daily routines and what the 
key barriers to and facilitators of adherence to 
ART were.  The interviews were conducted and 
audio-taped in Nepali by the first author who is 
a native speaker; sessions lasted one to one and-
a-half hours. Audio-recordings were transcribed 
verbatim in Nepali and then translated into 
English. To ensure accuracy, the translations 
were cross-checked for inter-rater reliability by 
the second author who is also a native Nepali 
speaker (26). Data were organized using NVivo 
8 and coded using a thematic analysis (22). The 
quotations cited in this paper best represented 
the range of ideas voiced around key themes. 
To maintain anonymity, these quotes are identi-
fied by gender and region alone, with a serial 
number designated by ‘P’. In addition, nurses 
and paramedics are all coded as ‘counsellor’. To 
assure quality of the data, the checklist was pi-
loted with two patients on ART and a care pro-
vider. Subsequently, some modifications were 
incorporated in the research instruments (27). 
Ethical permission for the study was obtained 
from the Nepal Health Research Council.
RESULTS
Major barriers of ART adherence themes were 
grouped into five interwoven categories: (i) eco-
nomic, (ii) individual patient-related, (iii) socio-
cultural, (iv) healthcare provision and system, 
and (v) drug-related barriers.
1. Economic barriers
Money emerged as the greatest barrier as most 
respondents reported economic worries relating 
to the costs of transport, prescription, and charg-
es for diagnosis. Interviewees often did not have 
the money to go to health facilities for repeat 
prescriptions (‘refill’), and, thus, transport costs 
emerged as a key theme. As subsistence farming 
was the main source of income for most PLWH, 
few had spare cash. One interviewee reported:
The reason….I missed my medication was….
the money. I need to manage 500 rupees (~£4) 
for bus fare every month to refill prescription of 
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ART. Who gives me this amount? No money! No 
source of income! How can I afford this [cost]? 
I do not have any alternative, except stopping 
treatment (P-12, Female, Far-western) 
Healthcare providers also concurred with this. 
Individuals often could not pay for travel to the 
ART centre before their drugs ran out. Other fi-
nancial constraints were the cost of registration 
and laboratory tests. A patient stated:
I need to refill my ART every end of a month. 
How could I get a registration charge?.…every 
month I need to pay registration fee of 40 rupees 
(~50 pence) and every three months for CD4 test 
(~£1 )….how can I get this amount? This is a big 
problem for me! (P-4, Female, Kathmandu)
One ART counsellor also noted that patients 
needed to bear the registration and diagnostic 
(laboratory) costs:
Patients themselves need to pay Rs. 40 (~0.40 
pence) as registration charge and Rs. 100 (~£1) 
for CD4 test and related travel cost; some are 
getting support from NGOs but hospital does 
not have a policy to provide free diagnostic 
test (P-26, Counsellor, Kathmandu)
This may remain a major reason why some indi-
viduals do not come to the health facility to re-
fill their prescriptions, even when the treatment 
itself is free of charge.
2. Individual patient-related barriers
In-depth interviews with all the participants 
recognized the following patient-related barri-
ers to adherence.
Perception about ART
Perceived self-efficacy is concerned with peo-
ple’s belief that they can exert control over their 
own motivation, through processes, emotional 
states, and patterns of behaviour. Some PLWH 
questioned the efficacy of ART. For example, 
one participant stated:
Rural people still do not believe this medicine 
[ART] works for HIV patients. HIV people will 
die eventually either taking or not taking ART. 
Why should I die by taking these malicious 
pills? They stopped taking medicine after ini-
tiating treatment (P-12, Female, Far-western) 
Similarly, the reaction of family members af-
fected adherence. Some interviewees stated that 
HIV is not currently curable and that treating 
PLWH was just a wastage of money. For exam-
ple, one respondent said: 
Some family members are not ready to get 
repeat prescription of ART because of HIV. 
There is no medicine to cure HIV. So, why 
should we send her to hospital? She will die 
soon. Why should we waste money and time? 
(P-14, Female, Highway)
Substance-misuse
Misuse of substance was mentioned by PLWH 
as contributing to non-adherence. A female par-
ticipant stated:
Some of male clients are not continuing 
their medication….they are not ready to go 
to hospital to refill prescription. They drink 
alcohol from early morning. How could they 
remember their ART time? (P-12, Female, Far-
western) 
Some stated that, at festival times, they were 
expected to drink alcohol and that this caused 
difficulty with remembering their medication 
routine. A male disclosed:
I need to attend parties and drink during 
festival times.…when I drink alcohol, I have 
great difficult to take my night dose [of ART]. 
I missed it many times (P-13, Male, Hill)
Healthcare providers also agreed that some pa-
tients had reported missing ART due to alcohol 
and drug consumption. Substance-users did not 
take medications on time because their sub-
stance-misuse made them relapse or forget the 
timing of their medication. One counsellor reit-
erated this issue, thus: 
It is….a problem with a few drug-using pa-
tients because their main focus was drug. Due 
to the addiction, they do not care about HIV 
….Drug is the most important thing for them 
(P-20, Counsellor, Highway)
Simply forgetting and being busy
Patients sometimes forgot their medication due 
to being busy or away from home. Some forgot 
when they were busy with their daily routine. 
One male disclosed:
I missed some doses [of ART] because I simply 
forgot. (P-10, Male, Hill)
Similarly, a female patient mentioned being 
busy and away from home: 
My children are very young, and last year my 
husband died….I am responsible for all work. 
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I am always very busy….I did not reach hos-
pital on time to collect medicine, do not have 
time to eat, and had missed some doses in dif-
ferent times (P-12, Female, Far-western)
Having responsibilities of family work, particu-
larly for single parents, could well account for 
non-adherence for those with a difficult journey 
to the nearest hospital as these, together with 
their work responsibilities, impeded the adher-
ence of some PLWH.
3. Sociocultural barriers 
HIV is still a sensitive social and cultural issue in 
Nepal, and our findings supported this.  
Barriers relating to religion and rituals 
People live in a community and need to abide 
by their local and traditional religious and cul-
tural rituals, which can influence adherence to 
ART. A Muslim reported:
I stopped my morning dose of ART during 
Ramadan.…I was sick and went to consult 
the doctor, and he told me not to stop at any-
time….now I am taking medicine when fast-
ing (P-16, Female, Highway) 
Similarly, a Hindu female ART-recipient also 
added:
During Teej [Hindu women’s fasting day], we 
won’t drink water the whole day....How can 
we take ART?….I am fasting but I take ART 
in empty stomach.…What can we do? (P-5, 
Female, Kathmandu)
A doctor stated:
I am not blaming all my patients but a few 
of Hindu women during Teej and Muslim 
patients in Ramadan have problems taking 
medicine.…a few Muslim patients did not 
take medicine in the morning because of Ra-
madan. They told me if they drink water dur-
ing the day, this is totally sinful (P-27, Doctor, 
Kathmandu)
Lack of family support
Lack of family support acted as a barrier to ad-
herence, and family arguments stopped them 
from taking medication, as one female partici-
pant explained:
I skipped two doses because of a family quar-
rel….my family did not allow me to visit hos-
pital (P-14, Female, Highway)
Some professionals also noted that patients 
without family support had lower adherence 
levels. A counsellor stated: 
One patient skipped medicine because no one 
brought medicine for her from the hospital. 
She was bed-ridden but family members did 
not bring medicine….Because the pills ran out 
and no one helped her, she skipped some dos-
es [of ART] (P-18, Counsellor, Far-western)
Thus, the combination of difficulty with access-
ing the hospital and an unhelpful family can 
negatively affect adherence. 
Stigma and discrimination
Most participants mentioned that they had 
experienced some form of discrimination and 
HIV-related stigma (or fear of stigma), which 
influenced adherence; this was especially so 
among women: 
I have not taken my medication two times 
because relatives and neighbours were in my 
house. I did not get time to take out medi-
cine from my drawer.…I have frequent prob-
lems to hide my medicine from others be-
cause I am living in a rented single room….
Oh! I cannot tell anyone (P-5, Female, Kath-
mandu)
The fear of being victimized and/or rejected by 
their family or community generated a fear of 
exposure, which in itself affected adherence:
I am worried about meeting my neighbours 
in hospital for refills [ART]. All the time I wor-
ry: “How can I hide from these people?” One 
day I did not refill my ART due to bumping 
into relatives (P-4, Female, Kathmandu)
Some healthcare providers also noted that 
PLWH selected ART sites where no one would 
know them:
Many patients still prefer visiting the distant 
hospital; they are not ready to go nearby. This 
is all about the fear of [disclosure to] other 
people (P-20, Counsellor, Kathmandu)
A doctor added:
Clients are still stigmatized….they fear other 
people.…‘What do they think?’, ‘What do 
they say?’....clients are not ready to take med-
icine in front of other people.…they choose 
the alternative and skip medication (P-27, 
Doctor, Kathmandu)
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4. Healthcare provision and system 
Distance
Nepal’s large rural hinterland, combined with a 
limited number of ART sites, was perceived to 
have a negative effect on adherence. Distance 
was a big concern, particularly outside Kathman-
du. The travelling distance to and from ART sites 
remained one of the most-challenging adherence 
issues, and it was frequently discussed by both 
PLWH and care providers: 
I need to walk more than one and half days 
to refill my medicine [ART].…this is very dif-
ficult at my age, not once a year, but every 
month (P-1, Male, Highway) 
Similarly, policy-makers agreed that distant and 
centralized ART-providing institutions limited 
adherence to ART: 
Treatment services are located in a limited 
number of central hospitals, which is a ma-
jor problem for PLWH seeking services. That’s 
definitely limiting their adherence….HIV 
treatment service is still not reaching the 
people in need (P-33, Policy-maker) 
Short period of medicine prescription 
Having very few ART institutions is itself a barrier 
to getting repeat prescriptions on time. The differ-
ent prescribing policies in different hospitals are 
also additional factors. Some clinicians prescribe 
ART drugs for one month, and others up to a max-
imum of two months. An interviewee stated:
Doctors prescribed ART only for a month. 
This is a very short time.…refilling ART every 
month is extremely difficult to adhere to this 
medication (P-5, Female, Kathmandu)
However, rural clinicians mostly prescribed two 
months of ART at a time, for example: 
I have to visit this hospital every two months to 
refill medicine….I have to arrange money and 
need to walk long distance, which is very hard 
not only for me but most of the PLWH [from 
hill districts].…to refill ART every two months 
is the main problem for me (P-10, Male, Hill)
Strikes (transportation blockades) 
Nepal’s political situation was very volatile at 
the time of the study, which led to frequent 
and unpredictable strikes. This often meant that 
main roads were blocked, leading to reduced 
ART adherence: 
Unexpected strikes are in fashion at the mo-
ment….bus-strikes….and last time even the 
hospital was on strike for a week….How can 
we take regular medicine?….Think about 
Nepal’s geography and distance, how can 
all ART-recipients receive medicine without 
missing any?’  (P-5, Female, Kathmandu)
Service providers also agreed that, due to fre-
quent and unexpected roadblocks, PLWH have 
no alternative other than to stop medication or 
miss some doses of their medicine.
5. Drug-related barriers
Side-effects of ART are one of the most-discussed 
themes in this study. Most participants had ex-
perienced side-effects, which increased non- 
adherence:
ART caused a problem rather than good 
health. I did not tolerate the pain, and I 
stopped for a while (P-9, Male, Highway).
Similarly, a woman found that ART caused 
physical problems:
.…ART caused me severe vomiting and grid-
diness. I was vomiting like I was going to die. 
If this condition would continue, how can I 
adhere to ART (P-17, Female, Kathmandu) 
Doctors agreed that side-effects, such as vomit-
ing, body-pain, and skin rashes, led some pa-
tients to stop taking ART.
Facilitators of adherence
Despite many barriers, five major themes were 
identified as facilitators of adherence to ART as 
follows: (i) trusting health workers, (ii) positive 
beliefs about ART, (iii) ART as a part of daily life, 
(iv) responsibilities for children, and (v) family 
and mechanical support.
Trusting health workers 
Patients’ trust in doctors and their guidance moti-
vated them to continue their medication. Support-
ive and interested practitioners reinforced good 
practice in their patients. Some PLWH felt respect 
for and support from healthcare staff. Where pa-
tients felt that their doctors had faith in them, their 
own hopes increased, and they believed more in 
their treatment. A male participant stated:
The doctor counsels me so nicely. He told me 
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HIV-positives are living longer, nobody will 
die soon due to HIV. A disease can happen to 
anyone, either rich or poor. ART will make 
you healthier and live longer. He is very wor-
ried about my medication. I could not stop it 
any time (P-13, Male, Highway)
One doctor spoke of patients having a higher trust 
in the medical profession than other counsellors:
They [PLWH] have good trust in doctors. They 
follow the doctors’ suggestions more strictly 
compared to other health workers (P-27, Doc-
tor, Kathmandu)
Positive beliefs about ART 
Fear of doing worse without adhering to ART 
was a prime motivator for adherence. Many pa-
tients were very optimistic about ART efficacy:
I do not want to imagine my life without this 
[ART] (P-3, Male, Kathmandu)
Another participant highlighted that PLWH do 
not have a choice:
I have two choices—whether I want to live or 
die. If I want to live longer, I must need to take 
ART, which I am doing and will be doing until 
another medicine (P-11, Male, Far-western)
Participants reported ART had increased their 
body-weight and appetite, reduced opportunistic 
infections, and improved their quality of life.
ART as a part of daily life 
Participants who could link ART to their daily rou-
tines found it much easier to remember to take it: 
I carry ART anywhere because I may go out 
and sometimes be late coming home. I must 
take these on time. See my bag, I have ART 
now (P-3, Male, Kathmandu)
Many had found strategies to incorporate taking 
medication into their lifestyle: 
Oh! ART is my life and is a part of my life just 
like the morning teeth brushing. My inner 
sight pushes me always that I have to take my 
medicine on time to feel good (P-14, Female, 
Highway)
Responsibilities for children
Caring for a family and having responsibility 
for looking after children was one of the most 
frequently-cited facilitators of adherence: 
I have the responsibility to care for my chil-
dren. I need to get my daughter married. She 
is 16 years old now (P-14, Female, Highway)
Healthcare providers also expressed the opinion 
that PLWH who worried about the future of their 
children showed a relatively good adherence: 
The motivation of patients for taking ART is 
usually to be healthy and live longer because 
they want to and care for their families (P-22, 
Counsellor, Highway)
Family and mechanical support 
Better understanding among family members 
was spoken of as something that improved ad-
herence. An interviewee recalled how her family 
helped her: 
.…I often forgot to take ART, my daughter 
asked me, mummy, have you taken your 
medicine today?…. She reminds me. Almost 
all the time she [daughter] brings a glass of 
water and pack of medicines (P-12, Female, 
Far-western)
Families also provide financial support: 
I do not need to worry about any ART-related 
costs. My parents give me money and support 
everything….I am alive today; it is because of 
my family (P-15, Female, Hill)
Some participants used electronic devices to re-
mind them to take their daily medication and 
found this support useful: 
I set different alarm tones in my mobile….I 
have recorded my own voice; It is time (Samaya 
bhayo), this alerts me (P-7, Male, Kathmandu)
DISCUSSION
Barriers
Some of the barriers identified in this study are con-
sistent with the literature from both developed and 
developing countries (10,12). Although ART drugs 
have been provided free of charge in Nepal, ART-
associated costs (including transport, prescription, 
and diagnostic tests) were by far the most-discussed 
theme relating to non-adherence as has been found 
elsewhere (12,28,29). Large income disparities per-
sist across ecological zones, rural and urban loca-
tions, and by caste and ethnicity, which affect all 
aspects of care, including patients’ ability to meet 
the ART-associated costs. One study from Africa 
has suggested that poor patients are able to achieve 
excellent rates of adherence with free laboratory 
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monitoring and subsidized ART (30). This is a use-
ful finding, and it is important that policy-makers 
in Nepal should consider subsidies for transport 
and other costs associated with ART when design-
ing treatment programmes. Our interviewees were 
concerned that physicians often prescribed ART for 
periods that were too short, thus increasing costs 
associated with transportation to collect ART drugs. 
Again, this is a finding that has been documented 
elsewhere (6). Patients were worried and reported 
that refilling ART prescription every month caused 
difficulties in adherence. The Government of Nepal 
needs to consider carefully the amount of medicine 
prescribed on each occasion as well as subsidizing 
the travel costs. Making available ART drug-
collection points in district hospitals rather than 
a limited numbers of selected central-level hospi-
tals may also help alleviate the (travel) cost issues 
around having only a short period between refills.
Most interviewees stated that, although patients 
were willing to take ART, they became non-
adherent because of difficulties in reaching the 
treatment centres due to unexpected transport 
strikes; long travel distance; geographical diffi-
culty, including lack of transportation services in 
many remote areas; and the seasonal deterioration 
of poorer road conditions during the rainy season. 
This has also been found to be the case with respect 
to maternity services in Nepal (31). Various stud-
ies have also found that  travel time and access to 
treatment centres were barriers to adherence else-
where (32,33) and that better access to care was 
significantly associated with optimal adherence 
(34). Interestingly, our findings revealed that, in 
urban areas, the problem was related to transpor-
tation blocks, while in rural areas, the difficulties 
were more about the long travel distance and the 
lack of availability of transportation services.  The 
current HIV/AIDS treatment programme in Nepal 
has been running in a limited number of ART sites 
and has largely ignored the existing public-health 
networks within the community. Therefore, any 
new policy needs to overcome the reduced access 
to medical care services by integrating ART into 
the mainstream healthcare rather than concen-
trating treatment in a limited number of ART cen-
tres, which may be hard to reach for the majority 
of patients.  
Patients’ beliefs, knowledge, and expectations 
regarding treatment strongly influence their 
medical decision-making (35). Our findings 
show that some participants questioned the ef-
ficacy of ART. PLWH who believed in the effi-
cacy of ART are more likely to adhere (36), and 
both education level of PLWH and educational 
programmes affect  adherence (37). Providing 
better information about HIV/AIDS reduces 
both fear and ignorance so that patients main-
tain their medication better (38). Our study re-
vealed that alcohol and illicit drug-use increased 
non-adherence, and similar findings have been 
reported elsewhere (12,36,39). In addition, one 
study showed that not using substances in-
creased adherence (40). 
Other barriers to adherence raised during the 
interviews included local cultural factors, espe-
cially religious activities and festivals, such as 
Teej for Hindu women and Ramadan for Mus-
lims. One possible intervention could come 
from Hindu and Muslim clergy who could stress 
the importance of continuing to take medicine 
during religious festivals. Our findings reinforce 
the importance of considering the religious and 
spiritual beliefs of PLWH as part of medical care. 
It is believed that most religions give freedom 
to eat on fasting days, especially for the sick, 
children, and older people. Hence, this message 
needs to be reinforced during counselling. 
Interviewees reported that stigma and discrimi-
nation was still widespread from both their 
own family and their local community. Some 
participants did not take medicine in front of 
people they knew due to fear of being identified 
as HIV-positive (41). Elsewhere, PLWH were un-
willing to seek treatment at the nearest health 
facility because of fear of stigmatization (42). In 
addition, the threat of social stigma may pre-
vent PLWH from revealing their status to others 
(43). It has been shown that PLWH who do not 
disclose their status to their family members or 
peers did worse in their treatment than those 
who disclosed (10). It is an important aspect of 
the development of evidence-based interven-
tions targeted at non-adhering  individuals that 
they are encouraged to disclose as this is linked 
with positive adherence practice, a result that 
has also been seen elsewhere (44). 
ART regimens have toxicities and adverse side-
effects that vary from mild to severe and acute 
to chronic, which can prevent adherence (45). 
In our study, patients who had side-effects were 
more likely to be non-adherent, and this has also 
been reported in several other studies conduct-
ed in both developed and developing countries 
(10,12). Hence, there is a need for continuing 
follow-up, clinical support, and counselling for 
patients who just started ART and for follow-up 
appointments to include instructions on how to 
cope with side-effects (46). Practitioners should 
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advise all clients on how to handle side-effects 
so that these cannot adversely influence ART 
adherence. 
Facilitating factors
Some of our interviewees were motivated to 
continue their ART by a desire to live longer and 
remain healthy for longer period. Tangible and 
emotional support delivered in culture-specific 
ways can be of help to foster adherence (47), 
for example, improving internal affective states, 
such as  beliefs and perceptions of  positive re-
sults of ART (48). Healthcare workers should 
continuously offer information and counselling 
to (a) prevent patients from stopping treatment 
and (b) make intake of medication a daily prior-
ity (46). 
Participants discussed the two-fold nature of so-
cial support systems as a barrier and as a facilita-
tor of adherence. Some people were accepting 
and supportive while others overtly or subtly 
distanced themselves from PLWH. Our find-
ings highlighted that family support increased 
the likelihood of patients to maintain optimal 
adherence. In addition, social and family sup-
port and access to care that anticipate patients’ 
individual needs play an important positive role 
(34,49). Particularly for women and children, 
family acted as a facilitator for adherence. A me-
ta-analysis reported that adherence is 1.74 times 
higher in patients from cohesive families (50). 
Some of our interviewees used electronic aids 
(alarm, mobile phone) as a tool to remind them 
of their medication, and others have shown that 
the use of such aids improved adherence (51). 
Therefore, healthcare providers should discuss 
with new starters and individuals in follow-up 
about the use of these aids. 
Finally, healthcare workers played an important 
role in supporting and encouraging patients to 
adhere to their medication. Good relationships 
with  care providers and trust in them improved 
adherence as has been found elsewhere (46). 
Healthcare providers who spent time explain-
ing things to patients positively influence ad-
herence and, thus, it is possible that time spent 
talking to significant influencing groups would 
help reinforce adherence (52). Service providers 
should promote optimal adherence by giving 
clear instructions, providing adequate medi-
cal follow-ups that address possible side-effects 
and how to handle these in order to reinforce 
adherence. Supportive and interested practitio-
ners can motivate and reinforce good practice in 
their patients.
Conclusions
Successful adherence to ART is highly depen-
dent on patients’ beliefs about the treatment, 
and subsequent treatment-seeking behaviours 
in practice. Our study revealed a range of barri-
ers to adherence: financial difficulties, treatment 
access, frequent transport blockades, religious or 
ritual obstacles, stigma and discrimination, and 
side-effects. Perceived benefits and trustworthy 
health workers were the most-frequently re-
ported facilitators. It is necessary to recognize 
and overcome the key barriers and promote 
measures to facilitate adherence. Priority should 
be given to improving adherence by provid-
ing (i) financial incentives, (ii) better access to 
treatment services, (iii) education and counsel-
ling to deal with religious and ritual obstacles, 
social stigma, and discrimination. All these are 
expected to be useful in overcoming the barriers 
to ART adherence. In addition, healthcare pro-
viders should explain the side-effects and how 
to handle these. It is crucial to prioritize adher-
ence because of its impact on treatment efficacy 
and ultimately on patients’ quality of life and 
life-expectancy. Policy-makers should be aware 
of these key barriers and consider social policy 
which encourages patients to achieve optimal 
adherence.
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